PIK3CG and cancer: During cancer treatment, the PI3K/Akt signaling pathway is often targeted to inhibit cancer cell proliferation; for example, the signaling pathway is controlled by the inhibition of lncRNA TDRG1 expression in osteosarcoma cells, thus interfering with their proliferation.131